TNFRSF10B and ovarian carcinoma: Microtubule targeting agent-induced upregulation of DR5 has previously been shown to sensitise breast and ovarian cancer cells to TRAIL-induced apoptosis (LaVallee et al, 2003; Wood et al, 2004).